combination product comprising an inhibitor of the src family of tyrosine kinases and receptor for the treatment or prophylaxis of pancreatic cancer, gemcitabine

摘要

The invention concerns a combination comprising an inhibitor of Src kinase and the cytotoxic agent gemcitabine, a pharmaceutical composition comprising such a combination and its use in the treatment or prophylaxis of cancer, particularly of pancreatic cancer.